Skip to content

Explore EATRIS as         Login

EATRIS
  • About
        • About Eatris

        • Who we are
        • People
          • EATRIS Meets
        • Impact
        • Jobs
        • Governance
          • How to join EATRIS?
        • Legal
        • Spotlight Programme
        • Institutes
        • Countries
          • Bulgaria
          • Croatia
          • Czech Republic
          • Finland
          • France
          • Italy
          • Latvia
          • Luxembourg
          • Netherlands
          • Norway
          • Portugal
          • Slovakia
          • Slovenia
          • Spain
          • Sweden
  • Services
        • Services

        • Research Services
          • Industry–Academia collaborations
          • Support for funding applications
          • COVID-19
        • Innovation Services
          • Mentoring
          • Regulatory Services
          • Translational Feasibility Assessment
          • Health Technology Assessment
        • EATRIS Expert Centres
        • Self-Service Resources
          • EU Tracer Factory
          • Innovation Helpdesk
          • Innovation Management Toolbox
          • Multi-omics Toolbox (MOTBX)
          • Orphan Drug Development Guidebook (ODDG)
          • Patient Engagement Resource Centre
          • Regulatory Database (RIS)
        • Education & Training
          • Transmed Academy
  • Projects
        • Training
          • EUROPEAN JOINT PROGRAMME ON RARE DISEASES (EJP RD)
          • IMIBIC-P2Med
        • Quality & Reproducibility
          • HAPLO-iPS
          • EATRIS Quality Initiative
          • EDITSCD
          • iRISE
          • OSCARS
          • TRUSTroke
        • Personalised Medicine
          • canSERV
          • EATRIS-CONNECT
          • ERDERA
          • ERICA
          • EUCAIM
          • HEAL
          • PRECISEU
          • RealiseD
          • RECOGNISED
          • REMEDi4ALL
          • SIMPATHIC
          • TRUSTroke
          • UMBRELLA
        • Research Infrastructure development
          • CANDLE
          • canSERV
          • EATRIS-CONNECT
          • ERIC Forum 2
          • iNext-Discovery
          • ISIDORe
          • RITIFI
          • Spotlight Programme
        • Industry collaborations
          • ERDERA
          • GSK Hub
          • RealiseD
          • REMEDi4ALL
        • Long-term partnerships
          • Translation Together
          • EATRIS Quality Initiative
          • EU-AMRI
          • NewFound
          • Patient engagement
        • Cross-Research Infrastructure Collaboration
        • Archive of past projects
  • Platforms
        • Platforms

        • ATMP
        • Small Molecules
        • Vaccines, Inflammation and Immune Monitoring
        • Biomarkers
        • Imaging & Tracing
  • News
  • Events
  • Resources
        • EATRIS 2024 Annual Report
          • Annual Report Archive
        • Strategic Plan 2023-2026
          • Strategic Plan 2019-2022
        • Sustainability Plan 2024-2030
        • Gender Equality Plan 2022-2023
        • Advocacy Efforts
        • Publications Citing EATRIS
          • How to acknowledge EATRIS
        • FUNDING OPPORTUNITIES FOR MEMBERS
        • Brand Centre
        • Glossary, abbreviations and acronyms
        • Leaflets
          • Platform leaflets
          • Support for Funding Applications leaflet
          • Technology Leaflets
          • EATRIS One-pager
  • Contact
Countries
All Bulgaria Croatia Czech Republic Finland France Italy Latvia Luxembourg Netherlands Norway Portugal Slovakia Slovenia Spain Sweden

Countries

All Bulgaria Croatia Czech Republic Finland France Italy Latvia Luxembourg Netherlands Norway Portugal Slovakia Slovenia Spain Sweden
10 June 2022
 

EATRIS Annual Report 2021 now published

7 June 2022
 

ISIDORe Launches Its Website and First Call Dedicated To SARS-CoV-2 and COVID-19

26 May 2022
 

Turku PET Centre Introduces New Total-Body PET Scanner

26 May 2022
 

EATRIS-Plus Meeting 2022 – Ideas, Inspiration and Innovation

23 May 2022
 

Toni Andreu confirmed as EATRIS Scientific Director for a further five years

6 May 2022
 

New publications from PERMIT project

2 May 2022
 

EATRIS part of project to enable market uptake of biomarkers

18 April 2022
 

EU-AMRI formally launched in Brussels

8 April 2022
 

EATRIS takes further steps towards normalising meaningful patient engagement in translational research

30 March 2022
 

Solidarity with refugee researchers of Ukraine

15 March 2022
 

INFARMED receives 2 Gold Medals for Distinguished Services from the Portugese Ministry of Health

9 March 2022
 

New publication by the EU-CardioRNA COST Action

2 March 2022
 

ISIDORe: A New Approach to Pandemic Preparedness Research in Europe

31 January 2022
 

Translation Together Partners Publish Article on Global Approach to Pandemics

27 January 2022
 

ERIC Forum publishes new article on the impact of research infrastructures

26 January 2022
 

EUPATI launches new collaborative platform to facilitate matchmaking between EUPATI Patients Experts and researchers

24 January 2022
 

EATRIS researchers receive funding for AI based digital diagnostics in Africa

21 January 2022
 

EATRIS researchers find a common risk factor for Alzheimer’s disease may predispose carriers to severe COVID-19

Posts navigation

Older posts
Newer posts

Sign up for news and updates

By signing up, you agree to our Privacy Policy

EATRIS ERIC logo

EATRIS ERIC
De Boelelaan 1117
1081 HV Amsterdam
The Netherlands

T +31 20 444 2254
E info@eatris.eu

WITH THANKS TO OUR FUNDERS AND PARTNERS




© Copyright EATRIS ERIC | Privacy Policy | EATRIS ERIC Statutes | EATRIS ERIC was established by Commission Implementing Decision 2013/640/EU of 7 November 2013